These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 207723)

  • 1. Thrombin generation and secretion of platelet Factor 4 during blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1978 Apr; 61(4):1102-6. PubMed ID: 207723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets and phospholipids in tissue factor-initiated thrombin generation.
    Butenas S; Branda RF; van't Veer C; Cawthern KM; Mann KG
    Thromb Haemost; 2001 Aug; 86(2):660-7. PubMed ID: 11522019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
    Jen CJ; McIntire LV
    Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resuscitative fluid you choose may potentiate bleeding.
    Brummel-Ziedins K; Whelihan MF; Ziedins EG; Mann KG
    J Trauma; 2006 Dec; 61(6):1350-8. PubMed ID: 17159676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The procoagulant effect of platelets on conversion of prothrombin to thrombin in nonanticoagulated plasma.
    White BN; Cox AC; Taylor FB
    J Lab Clin Med; 1980 Jun; 95(6):827-41. PubMed ID: 7381294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measurement of thrombin in clotting blood by radioimmunoassay.
    Shuman MA; Majerus PW
    J Clin Invest; 1976 Nov; 58(5):1249-58. PubMed ID: 993343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of platelet contractile force as a research and clinical measure of platelet function.
    Carr ME
    Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low affinity platelet factor 4 and high affinity platelet factor 4--two antiheparin factors secreted by human platelets.
    Niewiarowski S; Rucinski B; Budzynski AZ
    Thromb Haemost; 1980 Feb; 42(5):1679-80. PubMed ID: 6445092
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
    Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of platelet-rich plasma using thrombin receptor agonist peptide.
    Landesberg R; Burke A; Pinsky D; Katz R; Vo J; Eisig SB; Lu HH
    J Oral Maxillofac Surg; 2005 Apr; 63(4):529-35. PubMed ID: 15789326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of whole blood in thrombin generation in contact with various titanium surfaces.
    Thor A; Rasmusson L; Wennerberg A; Thomsen P; Hirsch JM; Nilsson B; Hong J
    Biomaterials; 2007 Feb; 28(6):966-74. PubMed ID: 17095084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.